FindTrial
Sign In

Clinical Study and Mechanism of Action of Naoning Fuxin Decoction in the Prevention and Treatment of Post-Stroke Depression

Clinical Study and Mechanism of Action of Naoning Fuxin Decoction in the Prevention and Treatment of Post-Stroke Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002230
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-17
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke depression

Interventions

trial group:Naoníng Fuxing Decoction
Control group:None

Sponsors

Binzhou Medical University Affiliated Hospital, Binzhou City, Shandong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the above diagnostic criteria for both traditional Chinese medicine and Western medicine; 2. Age 40–80 years old, HAMD-24 score 8–35 points (mild to moderate depression); 3. Post-stroke course of 2 weeks to 1 year, stable vital signs; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of severe organic disease, severe cognitive impairment, or mental disorders; 2. Use of antidepressants in the past 3 months;3. HAMD score > 35 points (severe depression) or suicidal tendencies; 4. Pregnancy, allergic constitution, or participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale-24;National Institutes of Health Stroke Scale (NIHSS);Traditional Chinese Medicine Syndrome Scoring;Activities of Daily Living (ADL) Scale Score;—

Countries

China

Contacts

Public ContactWang dong

Binzhou Medical University Affiliated Hospital, Binzhou City, Shandong Province

643355196@qq.com17865107771

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026